Logo image of OCFT

ONECONNECT FINANCIAL TECHNO (OCFT) Stock Fundamental Analysis

NYSE:OCFT - New York Stock Exchange, Inc. - US68248T2042 - ADR - Currency: USD

4.09  +0.39 (+10.54%)

Fundamental Rating

2

Overall OCFT gets a fundamental rating of 2 out of 10. We evaluated OCFT against 283 industry peers in the Software industry. OCFT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, OCFT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OCFT had negative earnings in the past year.
OCFT had a negative operating cash flow in the past year.
OCFT had negative earnings in each of the past 5 years.
OCFT had a negative operating cash flow in each of the past 5 years.
OCFT Yearly Net Income VS EBIT VS OCF VS FCFOCFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 -500M -1B -1.5B -2B

1.2 Ratios

OCFT has a Return On Assets (-0.58%) which is comparable to the rest of the industry.
The Return On Equity of OCFT (-1.06%) is better than 60.73% of its industry peers.
Industry RankSector Rank
ROA -0.58%
ROE -1.06%
ROIC N/A
ROA(3y)-9.35%
ROA(5y)-11.44%
ROE(3y)-24.17%
ROE(5y)-27.31%
ROIC(3y)N/A
ROIC(5y)N/A
OCFT Yearly ROA, ROE, ROICOCFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

The Gross Margin of OCFT (37.03%) is worse than 78.55% of its industry peers.
OCFT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for OCFT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5Y6%
OCFT Yearly Profit, Operating, Gross MarginsOCFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

OCFT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCFT has about the same amount of shares outstanding.
OCFT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OCFT has been reduced compared to a year ago.
OCFT Yearly Shares OutstandingOCFT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
OCFT Yearly Total Debt VS Total AssetsOCFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

OCFT has an Altman-Z score of 1.85. This is not the best score and indicates that OCFT is in the grey zone with still only limited risk for bankruptcy at the moment.
OCFT has a Altman-Z score (1.85) which is in line with its industry peers.
OCFT has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
OCFT has a Debt to Equity ratio (0.05) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.85
ROIC/WACCN/A
WACC11.58%
OCFT Yearly LT Debt VS Equity VS FCFOCFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 1.77 indicates that OCFT should not have too much problems paying its short term obligations.
OCFT has a Current ratio (1.77) which is comparable to the rest of the industry.
A Quick Ratio of 1.77 indicates that OCFT should not have too much problems paying its short term obligations.
OCFT has a Quick ratio (1.77) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
OCFT Yearly Current Assets VS Current LiabilitesOCFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.61% over the past year.
OCFT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.81%.
The Revenue has been growing by 21.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)54.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.15%
Revenue 1Y (TTM)-30.81%
Revenue growth 3Y3.45%
Revenue growth 5Y21.01%
Sales Q2Q%-50.56%

3.2 Future

OCFT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.56% yearly.
The Revenue is expected to decrease by -22.66% on average over the next years. This is quite bad
EPS Next Y114.62%
EPS Next 2Y36.82%
EPS Next 3Y29.56%
EPS Next 5YN/A
Revenue Next Year-41.53%
Revenue Next 2Y-34.05%
Revenue Next 3Y-22.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OCFT Yearly Revenue VS EstimatesOCFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
OCFT Yearly EPS VS EstimatesOCFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OCFT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OCFT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCFT Price Earnings VS Forward Price EarningsOCFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCFT Per share dataOCFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as OCFT's earnings are expected to grow with 29.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.82%
EPS Next 3Y29.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OCFT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONECONNECT FINANCIAL TECHNO

NYSE:OCFT (2/24/2025, 3:08:06 PM)

4.09

+0.39 (+10.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2024-08-14/bmo
Earnings (Next)N/A N/A
Inst Owners3.15%
Inst Owner Change-99.82%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap159.51M
Analysts85.71
Price Target2.31 (-43.52%)
Short Float %5.18%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)154.15%
EPS NY rev (3m)154.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-27.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-1.11
OCFYN/A
SpS11.25
BVpS11.11
TBVpS9.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.58%
ROE -1.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.03%
FCFM N/A
ROA(3y)-9.35%
ROA(5y)-11.44%
ROE(3y)-24.17%
ROE(5y)-27.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5Y6%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 1.85
F-Score4
WACC11.58%
ROIC/WACCN/A
Cap/Depr(3y)23.97%
Cap/Depr(5y)40.65%
Cap/Sales(3y)1.88%
Cap/Sales(5y)5.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.15%
EPS Next Y114.62%
EPS Next 2Y36.82%
EPS Next 3Y29.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.81%
Revenue growth 3Y3.45%
Revenue growth 5Y21.01%
Sales Q2Q%-50.56%
Revenue Next Year-41.53%
Revenue Next 2Y-34.05%
Revenue Next 3Y-22.66%
Revenue Next 5YN/A
EBIT growth 1Y50.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.78%
EBIT Next 3Y32.82%
EBIT Next 5YN/A
FCF growth 1Y-1107.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1107.21%
OCF growth 3YN/A
OCF growth 5YN/A